Science & Research
Parexel to Lead Eight Sessions on AI, RWE at DIA 2026
Sessions touch on AI-driven trial design and real-world evidence collection — tools with growing relevance for nutraceu…
All 513 stories
Science & Research
Alpha Tau FDA Clearance Expands REGAIN Glioblastoma Trial Enrollment
Early interim data signal a potential breakthrough in locoregional tumor control, though the therapy sits outside conve…
Science & Research
Liquidia to Present ASCENT Cough Data at PHA 2026 Conference
The Dallas conference brings together pulmonary hypertension researchers and clinicians as inhaled-therapy delivery for…
Industry & Business
TOMI Environmental Targets World Cup Biosecurity Market
Mass international travel events are accelerating operator interest in validated decontamination protocols — a trend wi…
Science & Research
RenovoRx TAMP™ Gemcitabine Data Published in Peer-Reviewed Journal
PET-CT imaging outperformed CT alone in detecting therapeutic response, potentially reshaping monitoring protocols for …
Science & Research
Caribou Biosciences Vispa-cel Posts 82% ORR in Lymphoma Trial
Single-dose outpatient tolerability profile positions the therapy for community oncology center expansion as allogeneic…
Industry & Business
Editor's Note: This Release Falls Outside Functional News Coverage
Functional News covers dietary supplements, functional foods, and nutraceutical ingredients. Pharmaceutical oncology tr…
Condition-Specific Health
CB-011 CAR-T Reports 83% Complete Response in Myeloma Trial
Single-dose durability data from EHA 2026 positions off-the-shelf CAR-T as a potential paradigm shift in hematologic on…
Ingredients & Formulation
OraSure FDA Clearance Expands At-Home STI Testing Access
The clearance signals continued regulatory momentum for consumer-directed diagnostics, a category intersecting with pre…
Science & Research
Oryzon's LSD1 Inhibitor Posts Updated AML Data at EHA 2026
Epigenetic enzyme inhibition enters a new data cycle as Oryzon's iadademstat shows continued signal in acute myeloid le…
Condition-Specific Health
Loma Linda & Nudj Health Launch Whole-Person Primary Care Model
The partnership signals growing institutional appetite for lifestyle-medicine frameworks that embed nutrition and funct…
Science & Research
Rein Therapeutics Expands Phase 2 IPF Trial to United Kingdom
The NASDAQ-listed clinical-stage biopharma is broadening its orphan pulmonary fibrosis program beyond the U.S. as IPF p…